Lupin launches additional strength of generic Lotrel capsules

06 Jul 2011 Evaluate

Pharma major, Lupin’s subsidiary - Lupin Pharmaceuticals Inc (LPI) has been granted the final approval by the United Food & Drug Administration (USFDA) for the company’s abbreviated drug application (ANDA) for Amlodipine/ Benazepril 5mg/40mg and 10 mg/40 mg capsules. The commercial shipments of the products have commenced.

This approval completes the product line as the company was granted final approval for Amlodipine/Benazepril 2.5 mg/ 10 mg, 5mg/10mg, 5mg/20 mg and 10 mg/20 mg capsules in February 2010.

Lupin’s Amlodipine/ Benazepril capsules are the AB rated generic equivalents of the Novartis Lotrel capsules indicated for the treatment of hypertension. Amlodipine/ Benazepril 5mg/40mg and 10 mg/40 mg capsules had annual sales of approximately $290 million for the twelve months ended March 2011.

Lupin Share Price

2078.05 -34.90 (-1.65%)
29-Dec-2025 15:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.30
Dr. Reddys Lab 1268.00
Cipla 1493.10
Zydus Lifesciences 904.25
Lupin 2078.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×